← All Sponsors
SPONSOR

Tvardi Therapeutics, Incorporated

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Hepatocellular Carcinoma
NCT05440708 Phase 1, Phase 2
Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma
United States View Trial →